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1. Introduction 
Transmissible spongiform encephalopathies (TSEs) are diseases that affect the central 
nervous system in both humans and animals. TSEs can be ascribed to conformational 
conversion of prion protein (PrP). “Prion” stands for “proteinaceous infectious particle”, 
which was discovered in the disease-transmitting material of infectious brain tissues and 
named by Prusiner (Prusiner 1982). The normal, cellular form of PrP (PrPC) is a α-helix-rich 
glycoprotein attached to the outer cell surface by a glycophosphatidyl inositol linkage. The 
biological role of PrPC remains ambiguous. Since Cu2+ is unique among divalent metal ions 
in its ability to bind to PrPC in the octarepeat region (four copies of the repeat 
ProHisGlyGlyGlyTrpGlyGln) in the N-terminal domain (Whittal et al. 2000), the prion 
protein has been suggested to play a role in maintaining cellular copper concentration and 
signal transduction (Brown et al. 1998; Mouillet-Richard et al. 2000). PrPC is non-infectious, 
whereas the abnormal and infectious, Scrapie isoform of PrP (PrPSc) has been considered to 
be the major infectious component of the genetic, sporadic and transmissible fatal neuro 
degenerative prion diseases that affect both human and animals (Prusiner 1998). PrPSc is rich  
in β-sheet structures and it has a pronounced tendency to misfold and to subsequently  
aggregate into highly stable and insoluble amyloid plaques. This PrPSc plagess are resistant 
to digestion by proteinase K, whereas PrPC is sensitive to digestion by proteinase K 
(Prusiner 1998). PrPSc is responsible for many diseases in humans, including Kuru, 
Gerstmann-Sträussler-Scheinker disease (GSS), fatal familial insomnia (FFI), Creutzfeldt-
Jakob disease (CJD) and the BSE-related, variant Creutzfeldt-Jakob disease (vCJD) (Horwich 
& Weissman 1997; Prusiner 1997; Will et al. 1996). The infectious nature of these fatal 
diseases differ from other infectious diseases in that the pathogen is a proteinaceous particle 
rather than typical pathogens, such as viruses, bacteria and fungi. Therefore, a “protein-
only“ hypothesis has been proposed (Griffith 1967; Prusiner 1998). A protein designated as 
“protein X“ has been proposed to be involved in structural conversion of PrPC into PrPSc 
(Telling et al. 1995) in the protein-only model. After decades of study on prion proteins, 
protein X has not been identified. Thus, the mechanism of how PrPC is converted into PrPSc 
remains ambiguous. 
The structure of prion proteins has been studied in human (Calzolai & Zahn 2003; Donne et 
al. 1997; Zahn et al. 2000), hamster (James et al. 1997) and mouse sequences (Gossert et al. 
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2005; Riek et al. 1996). The structure of truncated mouse PrP (121-231) has been solved and 
reveals a α-helical protein containing 52% of α-helical and 3% of β-sheet structures (PDB 
code: 1AG2, (Riek et al. 1996)). Furthermore, NMR structure of hamster prion 90-231 reveals 
a flexible N-terminus and a structured C-terminal fragment (125-228) containing 43% of α-
helical and 6% of β-sheet structures (PDB code: 1B10, (James et al. 1997)). The high flexibility 
of the N-terminus was confirmed in recombinant full-length hamster prion protein PrP 29-
231 (Donne et al. 1997). The representative NMR structure of mouse prion is shown in 
Figure 1. 
 
N-terminus
C-terminus
 
Fig. 1. The NMR structure of mouse prion protein (PDB code: 1AG2, (Riek et al. 1996)). The 
α-helical structures are represented by red ribbons, and the antiparallel β-sheet structure is 
colored in yellow. This figure was produced using the PyMol graphic package 
 
 
Fig. 2. Representative curve of nuclei-dependent polymerization model for amyloid 
formation 
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The formation of amyloid fibrils can be described by the polymerization model (Tsong & 
Baldwin 1972) illustrated in Figure 2. In this nucleation-dependent polymerization model, 
the conversion of proteins into nuclei that subsequently serve as seeds for amyloid fibrils is 
the rate-limiting step. Therefore, amyloid formation has a lag phase in which nucleation 
from protein monomers takes place. The spectroscopic signal for detecting amyloid fibrils is 
very weak during this nucleation phase, but the signal will enhance significantly during the 
fast polymerization catalyzed by the nuclei in the growth phase. Finally, the signal remains 
constant at a steady stateas that the ordered amyloid fibrils and protein monomers are at 
equilibrium. 
In previous studies of recombinant PrP, a partially folded intermediate of PrP 90-231 has 
been suggested (Apetri et al. 2004; Kuwata et al. 2002; Nicholson et al. 2002). These partially 
unfolded states can potentially initiate amyloid formation (Abedini & Raleigh 2009; Chiti & 
Dobson 2009). Consequently, extensive works on the interaction of samll molecules and PrP 
have been conducted in order to find pharmacological chaperones that can stabilize the 
structure of PrPC (Nicoll et al. 2010). Chemical chaperones is an important target in the 
developments of therapies for prion disease. In the study of protein folding, osmolyte is a 
well-know factor that acts as a chemical chaperone to assist proteins to fold. Furthermore, 
cellular osmolarity can be changed by the ion-transportations. An increase in intracellular 
osmolarity caused by ion-transoprtation resulting astrocyte dysfunction in neurological 
disorders has been reviewed (Seifert et al. 2006). Therefore, it is essential to study osmolytes 
that affect folding of prion proteins. The chemical structure of the osmolyte trimethylamine 
N-oxide (TMAO) is illustrated in Figure 3 that TMAO is a zwitterionic compound at neutral 
pH, but is positively charged below pH 4.7 (Lin & Timasheff 1994). TMAO is a well known 
protective osmolyte that can increase structural stability of proteins against chemical or 
temperature-induced denaturation (Baskakov et al. 1998; Bolen & Baskakov 2001; Celinski & 
Scholtz 2002; Gursky 1999; Qu et al. 1998). TMAO has an extraordinary ability to force 
thermodynamically unstable proteins to fold (Baskakov & Bolen 1998). In contrast, TMAO 
destabilizes proteins at low pH (Singh et al. 2005). 
 
 
Fig. 3. Chemical structure of zwitterionic TMAO in equilibrium with its cationic form 
A previous study by Tatzel and co-workers indicated that TMAO and the organic solvent 
dimethylsulfoxide (DMSO) prevent scrapie formation in vitro (Tatzelt et al. 1996). This study 
suggests a potential stratagy for preventing PrPSc by stabilizing the conformation of PrPC. In 
contrast, later studies indicated that TMAO destabilized the α-helical conformation of full-
length human prion at neutral pH at high temperature (Nandi et al. 2006) and human prion 
proteins at low pH (Granata et al. 2006). The structure of α-helix-rich prion protein is 
destabilized and the prion protein is converted to β-sheet structured oligomeric species 
(Nandi et al. 2006).  
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In this study, we examined the effect of TMAO on conformational stability in full-length 
mouse prion proteins (MoPrPs) and their structural conversion to amyloid fibrils. A possible 
mechanism of TMAO on fibril formation is proposed based on the nucleation-dependent 
polymerization model.  
2. Materials and methods 
We characterized TMAO-induced structural change in MoPrP by circular dichroism 
spectroscopy and 8-anilino-1-naphthalenesulfonic acid (ANS)-binding fluorescence assay, 
and compared the effect of TMAO on the formation of amyloid fibrils by thioflavin T (ThT) 
binding assay and transmission electron microscopy (TEM). 
Chemicals used in this work were purchased from Sigma Chemcial Co. (St. Louis, Missouri, 
USA), and used without further purification.  
2.1 Protein expression and purification  
Plasmid pET101 encoding mouse prion (23-231) was transformed into competent E. coli 
BL21 (DE3) and expressed in the form of inclusion bodies. The protein was purified on a Ni-
sepharose column according to a previously described procedure (Bocharova et al. 2005). 
The purity of the isolated protein was confirmed by SDS-PAGE. The correct native 
conformation, containing mainly α-helical structures, was confirmed by circular dichroism 
spectroscopy.  
2.2 Far-UV circular dichroism spectroscopy 
Far-UV circular dichroism spectra of mouse prion was recorded with a J-815 (Jasco, Japan) 
spectropolarimeter equipped with a Peltier temperatue control system (model PTC 423). For 
measurements in the far-UV region, a quartz cell with a path length of 0.1 cm was used in 
nitrogen atmosphere. For protein samples, the concentration of MoPrP was kept constant at 
10 μM in 10 mM 2-(N-morpholino)ethanesulfonic acid (MES, pH 6.0). Far-UV circular 
dichroism spectra between 200 and 250 nm were recorded. An accumulation of five scans 
with a scan speed of 50 nm per minute was performed at 20 °C. The thermal-induced 
denaturation of proteins was conducted by heating protein solutions at the rate of 1 °C/min, 
and measuring the molar ellipticity at 222 nm every 0.5 °C. The reading of molar ellipticity 
at 222 nm in accordance with temperature change was normalized for further analysis. The 
data were analyzed with Origin 6.0 from OriginLab (Northampton, Massachusetts, USA). 
2.3 ANS fluorescence assay  
ANS solution was added into 10 μM of TMAO-incubated MoPrP in 10 mM MES (pH 6.0) to 
a final concentration of 100 μM. For each sample, two fluorescence emission spectra were 
collected by a F-4500 fluorometer (Hitachi, Japan) with excitation either at 295 nm or 385 
nm, respectively.  
2.4 Fibril formation 
Fibril conversion was conducted at 20 µM protein in the solution containing 2 M guanidine 
hydrochloride (GdnHCl) and 50 mM MES (pH 6) at 37 °C as described in a previous study 
on mouse prion fibrils (Bocharova et al. 2005). At the end of the experiments, the fibril 
samples were dialyzed against 20 mM sodium acetate (pH 5.5) for further experiments. 
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2.5 ThT fluorescence assay of fibril conversion 
Aliquots withdrawn during the time course of incubation at 37 °C were diluted into 5 mM 
sodium acetate buffer (pH 5.5) to a final sample concentration of 0.5 μM. ThT solution was 
added to a final concentration of 10 μM. For each sample, two emission spectra were 
collected by a F-4500 fluorometer (Hitachi, Japan) equipped with a 150 W Xenon lamp. The 
fluorescence spectra were recorded from 470 to 550 nm with excitation wavelength of 
450 nm. The maximum fluorescence emission at 482 nm was determined. The reported 
fluorescence readings were average values for two measurements. 
2.6 TEM 
The aliquotes of mouse prion fibril samples were stained with 2% tungsten phosphoric acid 
onto carbon-coated 200-mesh copper grids. The samples were adsorbed onto copper grids 
for 30 sec and subsequently washed with PBS and mQH2O. The samples were air-dried 
before imaging. The TEM images were collected by a H-7100 TEM (Hitachi, Japan). The 
analysis of fibril length and width was carried out on WICF ImageJ software (National 
Institutes of Health). 
3. Results and discussion 
We characterized the effect of the osmolyte TMAO on the structure of MoPrP by far-UV 
circular dichroism spectroscopy and ANS-binding fluorescence assay. Furthermore, we 
tested the effect of TMAO on amyloid fibril formation. The prion fibrils grown at different 
concentrations of TMAO were analyzed by TEM. 
3.1 Secondary structure and protein stability  
We collected far-UV circular dichroism spectra for MoPrP at pH 6.0 at 20 °C. As shown in 
Figure 4, MoPrP has the typical feature of α-helical conformation as indicated by the circular 
dichroic signals at 208 nm and 222 nm. In prior investigations of TMAO and its effects on 
MoPrP structure, circular dichroism spectra of MoPrP in 2 M TMAO were recorded every 
hour. These spectra collected within 6 hours are very similar (data not shown). Since the 
extension of incubation does not affect the structural features of MoPrP, the following 
spectroscopic experiments were conducted without prolonged incubation.  
3.1.1 TMAO causes unfolding and destabilizes MoPrP 
We investigated the addition of TMAO in the range of 0.5 ~ 2 M and its effect on MoPrP 
using circular dichroism spectroscopy. The results are presented in Figure 4A. Osmolyte 
TMAO exhibits substantial interference below 205 nm. Therefore, the interfering circular 
dichroic signal was removed from the plot. In the absence of TMAO, MoPrP has clear 
circular dichroic feature of α-helical conformation at 208 and 222 nm. After addition of 0.5 M 
and 1.0 M TMAO, the circular dichroic signal indicative of α-helix structure at 208 nm 
decreased slightly, while the signal at 222 nm remained generally unchanged. Significantly, 
addition of 1.5 M and 2.0 M weakens the entire α-helical conformation. The unfolding of  
α-helical structure has been reported with similar work performed at low pH (Granata et al. 
2006). Consistently, the significant unfolding of prion proteins is carried out at > 1.0 M 
TMAO as illustrated in Figure 4B. Differently, the dichroic signal at 208 nm is affected by 
TMAO more severely than that at 222 nm. The dichroic signal at 208 nm dominants the 
dichroic curve of α-helix in the absence of TMAO, but this signal is largely weakened by the 
www.intechopen.com
 Advanced Understanding of Neurodegenerative Diseases 
 
316 
addition of TMAO. The dichroic curve of TMAO-affected partially folded α-helical structure 
observed in this work is not identical to the curves observed in the similar work performed 
at high temperature (Nandi et al. 2006). These results indicated that TMAO affect the 
structure of prion proteins differently under different conditions. At neutral pH, TMAO is 
zwitterionic, but it becomes cationic at low pH. Full-length prion protein includes polybasic 
N-terminal region 23-30 which is essential for effective folding into the native cellular 
conformation (Ostapchenko et al. 2008). Therefore, the differentiation of TMAO-induced 
conformational change at different pH values can be partially, if not all, ascribed to the 
interaction between TMAO and the polybasic N-terminal region.  
 
 
Fig. 4. (A) Far-UV circular dichroism spectra of 10 μM MoPrP measured after the addition of 
TMAO. (B) Comparison of mollar ellipticity at 222 nm and 208 nm in various concentration 
of TMAO 
TMAO is known to increase the melting temperature of various proteins (Arakawa & 
Timasheff 1985). Therefore, in addition to the conformation change, the structural stability 
of MoPrP in the presence of TMAO was examined with thermal-induced denaturation 
monitored by the molar ellipticity at 222 nm. The molar ellipticity was normalized to represent 
the fraction of unfolded proteins as presented in Figure 5.  
 
 
Fig. 5. Thermal-induced denaturation of MoPrP monitored the circular dichroic signal at  
222 nm 
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The curves of heat-induced denaturation can be described by a cooperative two-state model 
of denaturation in which proteins are transited between natively folded states and 
denatured unfolded states. By monitoring the circular dichroic signal at 222 nm, the natively 
folded MoPrP has the minimum intensity, whereas fully unfolded proteins has the 
maximum readings. These denaturation curves can be analyzed based on the Gibbs-
Helmholtz equation:  
 
U m p m
m m
T TΔG (T) ΔH (T )(1 ) ΔG [(T T) Tln( )]
T T
° °= ° − − − +  (1) 
Based on the above equation, the melting temperature (Tm) of MoPrP can be determine. In 
the absence of TMAO, the Tm of MoPrP is 68.63 °C. Addition of 0.5 M TMAO does not affect 
the thermal-denaturation curve significantly, as the Tm value was calculated to be 68.19 °C. 
In the presence of 1.0 ~ 1.5 M TMAO, the thermal-denaturation curve shifted toward low 
temperature significantly, as MoPrP starts to denature at ~32 °C. In contrast to the 
denaturation curve collected in the absence of TMAO, the thermal-denaturation curves of 
MoPrP treated with ≥ 1.0 M TMAO are not typical of cooperative two-state unfolding. These 
curves implies that TMAO changes the unfolding pathway, and that more intermediates are 
present at high concentration of TMAO.  
3.2 TMAO-induced conformational change within the native state 
The hydrophobic dye ANS has been widely used to detect the conformational changes in 
proteins, as ANS preferentially binds to hydrophobic protein surfaces. The binding of ANS 
to hydrophobic area causes significant increase in the fluorescence emission of ANS. 
Therefore, we detected ANS fluorescence emission upon excitation at at 385 nm to detect the 
change of hydrophobicity of MoPrP as presented in Figure 6. Clearly, ANS-bound MoPrP 
emits fluorescence at 470 nm and 495 nm upon excitation at 385 nm which indicates the 
presence of two distinct ANS-binding pockets. Addition of 0.5 M TMAO weakens the 
fluorescence emission of ANS slightly, but addition of 1.0 ~ 2.0 M TMAO substantially 
increased ANS fluorescence. The increase of ANS emission at 470 nm is more pronounced 
than the fluorescence at 495 nm. It indicates that the hydrophobicity represents by 470 nm is 
more sensitive to TMAO than the other one at 495 nm. Overall, this result indicates that 
TMAO increases hydrophobic surface at two distinct sites in MoPrP.  
 
 
Fig. 6. Fluorescence of ANS in the absence and in the presence of TMAO upon excitation at 
385 nm 
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In addition to the change of hydrophobicity in MoPrP, we detected ANS fluorescence 
emission upon excitation at 295 nm to study the TMAO-induced conformational change. 
Excitation at 295 nm excites tryptophan (Trp) and ANS at the same time, but this excitation 
causes the energy transfer from Trp (donor) in the N-terminus to ANS (acceptor). As the 
energy transfer efficiency (E) is determined by the distance of donor-acceptor (r) in the 
relation of E α r-6, the fluorescence spectra with excitation at 295 nm provide the distance 
information between Trp and ANS-bound residues. As illustrated in Figure 7, in the absence 
of TMAO, MoPrP has fluorescence emission at 350 nm and 485 nm arising from Trp and 
ANS-binding, respectively. Upon the addition of TMAO, the energy in Trp transfers to 
MoPrP-bound ANS efficiently that the signal of Trp at 350 nm is completely abolished, and 
the fluorescence of ANS is significantly enhanced. The fluorescence spectra of ANS in the 
presence of TMAO illustrate a strong peak at 408 nm, a medium, broad peak at ~460 nm and 
a weak, broad peak at ~490 nm overlapped with the broad peak at 460 nm. The fluorescence 
at 490 nm is a typical emission of ANS-binding as observed in Figure 6. This weak signal at 
490 nm could be ascribed to MoPrP-bound ANS molecules that do not accept energy from 
Trp efficiently. As the addition of TMAO causes the peaks at 408 nm and at 460 nm to 
increase at different degrees, it is predicted that there are two distinct hydrophobic pockets 
near the N-terminal region but away from Trp with different distances. 
 
 
Fig. 7. Fluorescence of ANS in the absence and in the presence of TMAO upon excitation at 
295 nm 
3.2 Fibril conversion in TMAO 
Partially unfolded MoPrP can potentially initiate formation of amyloid fibrils (Abedini & 
Raleigh 2009; Chiti & Dobson 2009). In 2 M GdnHCl, MoPrP is about half folded and is 
readily converted into amyloid fibrils (Breydo et al. 2005). Formation of amyloid fibrils can 
be monitored by ThT-binding fluorescence because the fluorescence of ThT is greatly 
enhanced when ThT binds to β-sheet rich structures, which are the main structures found in 
the amyloid fibrils (LeVine 1999). Therefore, the intensity of ThT-binding fluorescence 
represents the amount of amyloid fibrils converted from protein monomers in the absence of 
TMAO. As illustrated in Figure 8, the kinetics of fibril conversion shows sigmoidal curves. 
The MoPrP starts to form amyloid fibrils after 6 hours of incubation as monitored by ThT-
binding fluorescence. The prion fibrils grow rapidly such that the maximum ThT 
fluorescence reached ~400 after 8 hours of amyloid fibril conversion. In the presence of 0.5 
www.intechopen.com
 The Effects of Trimethylamine N-Oxide on the Structural Stability of Prion Protein 
 
319 
or 1.0 M of TMAO, the amyloid fibrils grow very well such that the maximum values of ThT 
fluorescence are higher in comparison to those in the absence of TMAO. When the 
concentration of TMAO is increased to 1.5 M and above, MoPrP rarely converts to amyloid 
fibrils as indicated by low ThT-binding fluorescence.  
 
 
Fig. 8. Kinetic traces for amyloid fibril formation from MoPrP monitored by ThT-binding 
fluorescence in the presence of 2 M GdnHCl and various concentrations of TMAO at pH 6.0 
at 37 °C. The fluorescence readings were average values of two measurements 
The quantity of prion fibrils judged by the maximum ThT fluorescence in the presence of 
TMAO is presented in Figure 9A. Clearly, addition of 0.5 and 1.0 M TMAO promotes 
amyloid formation as the reading of ThT-fluorescence is greatly enhanced in comparison to 
that in the absence of TMAO. In contrast, when the concentration of TMAO was increased 
further, the fibril conversion was inhibited. It is interesting to observe enhancement of fibril 
conversion by TMAO at ≤ 1.0 M. This result is consistent with previous work performed on 
α-synuclein that 1.0 M TMAO yields large amount of fibril whereas 2.0 and 3.0 M of TMAO 
inhibits the fibril formation (Uversky et al. 2001). 
 
 
Fig. 9. (A)The quantity of amyloid fibrils converted from MoPrP monitored by the 
maximum of ThT-binding fluorescence measured two times, and (B) the calculated lag 
phase of fibril conversion in the absence and in the presence of TMAO 
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The formation of amyloid fibrils in the presence of 0 ~ 1.5 M TMAO follows the nucleation-
dependent polymerization model as illustrated in Figure 2. According to this nucleation-
dependent polymerization model, the lag phase of amyloid formation from MoPrP can be 
determined by fitting the time-dependent changes in the ThT fluorescence (F) over time (t) 
of the reaction as shown in the following equation (Bocharova et al. 2005): 
 
t)]exp[k(t1
ΔF
FF
m
0 −++=  (2) 
Where F0 is the minimum level of ThT fluorescence during the lag phase, ΔF is the difference 
of ThT fluorescence between the maximum level (steady state) and the minimum level (lag 
phase), k is the rate constant of fibril growth (h-1), and tm is the observed time at the 
midpoint of transition. The lag time (tl) of fibril formation can be calculated as: 
 
k
tt
ml
2−=  (3) 
According to these two equations, the lag time for fibril formation in the presence of 0, 0.5 
and 1.0 M TMAO was determined as presented in Figure 9B. Previous work on fibril 
conversion from α-synuclein in the presence of TMAO reported acceleration of amyloid 
formation in a wide range of TMAO concentration (1.0 ~ 3.0 M) due to osmolyte-induced 
stabilization of the partially folded intermediate (Uversky et al. 2001). Similarly, TMAO 
stabilizes some partially folded intermediates. However, these partially folded intermediates 
slightly disfavour the nucleation reaction resulting in slight extension of the nucleation 
phase and also the following growth phase.  
3.3 Morphology of prion fibrils grown with TMAO 
Variation of conditions for fibril formation from the identical protein can yield different 
morphology. For example, Makarava and Baskakov have observed curved and straight 
fibrils from the same mouse prion protein and identical solvent conditions but different in 
the shaking speed (Makarava & Baskakov 2008). Therefore, we investigated the morphology 
of mouse prion fibrils by electron microscopy. In our experiment, for mature mouse prion 
fibrils grown in 2 M GdnHCl, the length is mostly longer than 500 nm, and the width is 
about 20 nm as illustrated in Figure 10.  
 
 
Fig. 10. TEM image of mature prion fibrils grown in 2 M GdnHCl at pH 6.0 at 37 °C. The 
scale bar represents 500 nm 
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The growth phase of fibril conversion in the absence of TMAO is very short, whereas this 
elongation process takes longer in the addition of TMAO. To compare the morphology of 
prion fibrils during elongation in the absence and in the presence of TMAO, we collected 
TEM images of fibril samples in the middle point of growth phase. As illustrated in Figure 
11, the prion fibrils grown in the absence of TMAO are long and straight, whereas fibrils 
converted in the presence of TMAO look like short rods.  
 
 
Fig. 11. TEM images of mouse prion fibrils at the middle point of growth phase (A) in the 
absence of TMAO and (B) in the presence of 1.0 M TMAO. The scale bar represents 200 nm 
Oligomers, protofibrils and mature fibrils involved in the formation of amyloid fibrils are 
typically distinguished by the length and width of the fibrils. Therefore, we statistically 
compared the length and the width of prion fibrils converted in the absence and in the 
presence of 0.5 M and 1.0 M TMAO. As illustrated in Figure 12A, in the absence of TMAO, 
the fibril length is populated in two groups including one normal distribution between  
60 ~ 180 nm and an elongation at > 180 nm. Prion fibrils with the addition of 0.5 M TMAO 
are normally distributed between 20 ~ 160 nm and the most populated length is 80 ~ 120 
nm. Increasing TMAO to 1.0 M shortens the prion fibrils, so that the fibril length ranges 
from 20 to 140 nm with the most populated length being 40 ~ 60 nm. The average length of 
prion fibrils is 144 nm in the absence of TMAO. Addition of TMAO shortens the average 
length of prion fibrils to 92 and 61 nm in the presence of 0.5 M and 1.0 M, respectively. In 
contrast to the fibril length, the width of prion fibrils is similar as illustrated in Figure 12B, 
and the average of the width is 19 nm regardless the presence of TMAO. 
The structural effect of osmolyte TMAO on prion proteins and fibril conversion has been 
investigated extensively in this work. At pH 6.0, 20 °C, the α-helical conformation of MoPrP 
is unfolded by TMAO. When the concentration of TMAO is low at ≤ 1.0 M, the degree of 
unfolding is small and the fibril conversion takes place on the mostly folded α-helical 
structures. In contrast to low concentration of TMAO, high concentration of TMAO at >1.0 
M largely unfolds the α-helix and this unfolding inhibits amyloid formation completely. In 
other words, low concentration of TMAO decellarates the prion nucleation represented by 
lag phase in nucleation-dependent polymerization model, whereas TMAO enhances the 
growth of prion fibrils. This contrast effect indicates that the structural requirement of prion 
proteins in nucleation and in fibril elongation is different. The importance of partial 
unfolding of prion in amyloid formation has been suggested (Apetri et al. 2004; Kuwata et al. 
2002; Nicholson et al. 2002). The structure of partially folded prion protein that initiates 
amyloid formation remains unclear. Our recent computational simulation proposed that the  
www.intechopen.com
 Advanced Understanding of Neurodegenerative Diseases 
 
322 
 
Fig. 12. Histrogram of length and width of prion fibrils measured on 100 fibrils in the 
absence and in the presence of 0.5 M and 1.0 M TMAO 
 
 
Fig. 13. A scheme illustrating the proposed effect of TMAO based on nucleation-dependent 
polymerization model  
denatured state of prion protein is partially folded with α-helical conformation (Lee & 
Chang 2010). In prion nucleation, high α-helical conformation is preferred and 
intermolecular β-sheet interactions occur between prion monomers (Lee et al. 2010). This 
interaction of intermolecular β-sheets is most likely the initiation of nucleation. This 
intermolecular interaction might be correlated with a double-layered filament within one 
fibril as observed by atomic force microscopy (Anderson et al. 2006). When the α-helical 
structure is mostly lost and the intermolecular interaction is largely weakened, the amyloid 
formation can not take place due to failure of nucleation as illustrated in Figure 13. After 
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nuclei are formed as fibril seeds, the elongation requires stable interactions between nuclei 
and proteins. As amyloid fibrils have been proposed to have hydrophobic interior (Buchete 
& Hummer 2007; Carroll et al. 2006), the area of the hydrophobic surface is important in 
fibril elongation. The hydrophobicity at the ANS-binding pockets that accept energy from 
Trp is induced significantly by TMAO, and the high hydrophobicity promotes hydrophobic 
interactions of nuclei and proteins to form the hydrophobic interior. Notably, in the 
presence of low concentration of TMAO, the amount of fibrils is significantly increased, but 
the fibril length is shortened in the middle of growth phase. This phenomenon could be due 
to adjustment of interaction between nuclei under high hydrophobicity as judged by long 
growth phase in the presence of TMAO. Taking togther these findings, a certain amount of 
α-helical conformation seems to be required in the structural conversion of prion proteins in 
nucleation, and hydrophobic interaction is essential in fibril elongation.  
4. Conclusion 
In this study, we have investigated the structural effect of osmolytes TMAO on MoPrP 
proteins and the features of mouse prion fibrils. Low concentration of TMAO alters α-helical 
structures resulting deceleration of nucleation serving as fibril seeds, but TMAO enhances 
hydrophobicity promoting fibril growth. High concentration of TMAO inhibits amyloid 
formation completely by inducing loss of α-helical conformation. This study provides more 
information in the details of molecular structure and interaction in amyloid formation. 
These findings are essential in further search for therapeutic therapies for prion disease. 
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